IFA capital

IFA Capital Management is a Charlottesville, VA-based investment management firm specializing in the life sciences sector. The firm applies a disciplined, research-intensive framework to biotechnology investments, emphasizing sustainability to advance medical innovation for a low-carbon economy. This approach includes a strategic collaboration with Rho Impact, which integrates climate data into its due diligence processes for evaluating potential investments. Operating as a hedge fund, IFA Capital Management manages concentrated investments in public and private life sciences companies, serving capital allocators and portfolio companies across healthcare capital markets. The firm, which launched on January 1, 2026, is led by co-founders Kellie Seringer, who serves as Portfolio Manager and previously founded Symmetry Capital Management, and Matt Johnson, who co-founded the firm in 2026.